(Q39522697)

12 September 2017

title

Selection of New Human Foreskin Fibroblast Cell Strains for Interferon Production (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

9 November 2022

author name string

J. Vilcek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A83097

9 November 2022

E. A. Havell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A83097

9 November 2022

M. L. Gradoville

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A83097

9 November 2022

M. Mika-Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A83097

9 November 2022

W. H. Douglas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A83097

9 November 2022

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

12 September 2017

http://link.springer.com/content/pdf/10.1007/978-1-4615-9080-4_9

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Advances in Experimental Medicine and Biology

9 November 2022

published in

1 reference

12 September 2017

volume

110

1 reference

12 September 2017

page(s)

101-118

1 reference

Inhibition of respiratory virus infection by locally applied interferon

12 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

9 November 2022

2

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Topical therapy of ulcerative herpetic keratitis with human interferon

9 November 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

9 November 2022

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Two antigenically distinct species of human interferon

9 November 2022

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Distinct Molecular Species of Human Interferons: requirements for Stabilization and Reactivation of Human Leukocyte and Fibroblast Interferons

9 November 2022

7

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Antigenic, physicochemical, and biologic characterization of human interferons

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Human Fibroblast and Leukocyte Interferons Show Different Dose-Response Curves in Assay of Cell Protection

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Pronounced antiviral activity of human interferon on bovine and porcine cells

9 November 2022

10

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Mass production of human interferon in diploid cells stimulated by poly-I:C

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

Detection of anaerobic mycoplasmas in cell cultures

9 November 2022

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-9080-4_9

9 November 2022

Identifiers

0 references

1 reference